insights_auto
Miks on 524494 langenud? 3,51%?
Uurige põhjalikumaltchevron_right
524494:BOM
IPCA Laboratories Ltd
1 845,00 ₹
arrow_downward
−3,51%(−67,20) 1 p
16. okt, 15:30:00 GMT +5:30 · INR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 524494 põhistatistika genereerimine…
Ava
1 913,95 ₹
Kõrge
1 913,95 ₹
Madal
1 812,60 ₹
Turu kapit.
468,21Â mld
Keskm. maht
27,90Â tuh
Maht
12,00Â tuh
Dividend
0,33%
Kvartaalne dividend
1,50 ₹
Dividendikuupäev
7. aug 2026
Hinna ja tulu suhe
35,74
52 näd kõrgeim
2 039,30 ₹
52 näd madalaim
1 252,95 ₹
Aktsiatulu
51,63 ₹
Käibivad aktsiad
126,35Â mln
Töötajate arv
17Â tuh
Ava
1 913,95 ₹
Kõrge
1 913,95 ₹
Madal
1 812,60 ₹
Turu kapit.
468,21Â mld
Keskm. maht
27,90Â tuh
Maht
12,00Â tuh
Dividend
0,33%
Kvartaalne dividend
1,50 ₹
Dividendikuupäev
7. aug 2026
Hinna ja tulu suhe
35,74
52 näd kõrgeim
2 039,30 ₹
52 näd madalaim
1 252,95 ₹
Aktsiatulu
51,63 ₹
Käibivad aktsiad
126,35Â mln
Töötajate arv
17Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Detroit Free Press
·
8 minuti eest
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
Yahoo Finance
·
40 minuti eest
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Binance
·
29 minuti eest
Binance Market Update | S&P 500 Near a Record While Half the Russell 3000 Is in a Bear Market — Bitcoin Held as AI Credit Spreads Blew Out and Strategy Fell 9%
MarketWatch
·
13 tunni eest
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profiil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Teave üksuse IPCA Laboratories Ltd kohta